179 related articles for article (PubMed ID: 2430012)
21. Effect of endogenous digoxin-like factor and digoxin antibody on myocardial Na+, K(+)-pump activity and ventricular arrhythmias in acute myocardial ischaemia in rats.
Bagrov AY; Fedorova OV; Roukoyatkina NI; Zhabko EP
Cardiovasc Res; 1993 Jun; 27(6):1045-50. PubMed ID: 8221762
[TBL] [Abstract][Full Text] [Related]
22. Role of digitalis-like substance in experimental insulin-dependent diabetes mellitus hypertension.
Chen S; Yuan C; Clough D; Haddy FJ; Pamnani MB
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S20-1. PubMed ID: 7508018
[TBL] [Abstract][Full Text] [Related]
23. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.
Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
Circulation; 2002 Mar; 105(9):1122-7. PubMed ID: 11877366
[TBL] [Abstract][Full Text] [Related]
24. Evidence for a digitalis-like substance in the hypothalamopituitary axis in rats: implications in the central cardiovascular regulation associated with an excess intake of sodium.
Takahashi H; Matsuzawa M; Okabayashi H; Suga K; Ikegaki I; Yoshimura M; Ijichi H; Okamura H; Murakami S; Ibata Y
Jpn Circ J; 1987 Oct; 51(10):1199-207. PubMed ID: 2828705
[TBL] [Abstract][Full Text] [Related]
25. Plasma digitalis-like activity and cytosolic Ca2+ in essential hypertension.
Le Quan Sang KH; Pernollet MG; Meyer P; Devynck MA
Am J Hypertens; 1990 Mar; 3(3):171-5. PubMed ID: 2157464
[TBL] [Abstract][Full Text] [Related]
26. Sodium pump inhibition and regional expression of sodium pump alpha-isoforms in lens.
Tao QF; Hollenberg NK; Graves SW
Hypertension; 1999 Nov; 34(5):1168-74. PubMed ID: 10567200
[TBL] [Abstract][Full Text] [Related]
27. Renal transplantation and red blood cell sodium transport: role of prednisone treatment.
Bosch RJ; Hernando N; Plaza JJ; Casado S; Lopez-Novoa JM
Nephrol Dial Transplant; 1991; 6(4):286-91. PubMed ID: 1652707
[TBL] [Abstract][Full Text] [Related]
28. Erythrocyte Na,K pump activity and arterial hypertension in uremic dialyzed patients.
Boero R; Guarena C; Berto IM; Deabate MC; Rosati C; Quarello F; Piccoli G
Kidney Int; 1988 Nov; 34(5):691-6. PubMed ID: 2848975
[TBL] [Abstract][Full Text] [Related]
29. Digoxin-like immunoreactivity increases with intravenous infusion of saline in rats.
Takahashi H; Matsusawa M; Nishimura M; Ikegaki I; Nakanishi T; Yoshimura M
Clin Exp Pharmacol Physiol; 1991 Jul; 18(7):505-8. PubMed ID: 1655319
[TBL] [Abstract][Full Text] [Related]
30. Digitalis-like and vasoconstrictor effects of endogenous digoxin-like factor(s) from the venom of Bufo marinus toad.
Bagrov AY; Roukoyatkina NI; Fedorova OV; Pinaev AG; Ukhanova MV
Eur J Pharmacol; 1993 Apr; 234(2-3):165-72. PubMed ID: 8387009
[TBL] [Abstract][Full Text] [Related]
31. [Genetic hypertension in the SHR rat and circulating digitalis compounds].
Wauquier I; Pernollet MG; Grichois ML; Meyer P; Devynck MA
Arch Mal Coeur Vaiss; 1987 Jun; 80(6):982-6. PubMed ID: 2821951
[TBL] [Abstract][Full Text] [Related]
32. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
[TBL] [Abstract][Full Text] [Related]
33. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
[TBL] [Abstract][Full Text] [Related]
34. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
[TBL] [Abstract][Full Text] [Related]
35. Circulating digoxin-like immunoreactivity in renal hypertensive rabbits: lack of modulation by alterations in dietary sodium intake.
Scott PJ; Little PJ; Bobik A
J Hypertens; 1988 Mar; 6(3):205-9. PubMed ID: 3361119
[TBL] [Abstract][Full Text] [Related]
36. Increased dietary potassium and magnesium attenuate experimental volume dependent hypertension possibly through endogenous sodium-potassium pump inhibitor.
Pamnani MB; Bryant HJ; Clough DL; Schooley JF
Clin Exp Hypertens; 2003 Feb; 25(2):103-15. PubMed ID: 12611422
[TBL] [Abstract][Full Text] [Related]
37. [Endogenous digitalis-like substance and Na-K-ATPase inhibitor in cardiovascular and renal disease].
Okamoto S
Nihon Naibunpi Gakkai Zasshi; 1988 Jan; 64(1):39-50. PubMed ID: 2837414
[TBL] [Abstract][Full Text] [Related]
38. Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients.
Vasdev S; Johnson E; Longerich L; Prabhakaran VM; Gault MH
Clin Nephrol; 1987 Apr; 27(4):169-74. PubMed ID: 3034459
[TBL] [Abstract][Full Text] [Related]
39. An endogenous digitalis-like compound extracted from human urine: biochemical and chemical studies.
Cloix JF; Crabos M; Grichois ML; Meyer P
Can J Physiol Pharmacol; 1987 Aug; 65(8):1522-7. PubMed ID: 2825938
[TBL] [Abstract][Full Text] [Related]
40. Digoxin-like immunoreactivity, displacement of ouabain and inhibition of Na+/K+ ATPase by four steroids known to be increased in essential hypertension.
Seccombe DW; Pudek MR; Nowaczynski W; Humphries KH
Clin Biochem; 1989 Feb; 22(1):17-21. PubMed ID: 2539926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
